Title: Multiple Sclerosis Oral Treatment Approved in Canada
Description: Gilenya (fingolimod) is the first disease modifying oral therapy developed for the relapsing-remitting form of multiple sclerosis (MS).
URL: https://www.disabled-world.com/health/autoimmunediseases/ms/gilenya-fingolimod.php
Confused by Google's Search Result Shambles? View more Disabled World content by adding us as a source for relevant searches. Click the button above, find Disabled World on the Google page that opens, and check the box on the right.